RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.250
+0.100 (8.70%)
Dec 20, 2024, 4:00 PM EST - Market closed
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $29.98 million as of December 20, 2024. Its market cap has increased by 352.31% in one year.
Market Cap
29.98M
Enterprise Value
20.42M
1-Year Change
352.31%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $29.98M, a decrease of -56.32%. That is a compound annual growth rate of -22.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 29.98M | 22.44% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeueHealth | 31.53M |
| Tempest Therapeutics | 31.06M |
| Nortech Systems | 30.52M |
| ProMIS Neurosciences | 30.07M |
| Incannex Healthcare | 29.64M |
| CytoMed Therapeutics | 29.54M |
| DURECT | 29.49M |
| IGC Pharma | 29.35M |